Structural Analysis of von Willebrand Factor

Abstract

The von Willebrand factor (VWF) is a large, multidomain glycoprotein whose modular organization facilitates its diverse physiological functions, primarily in hemostasis. Each domain contributes distinct molecular properties that collectively enable VWF to sense shear force, mediate platelet adhesion, and stabilize coagulation factor VIII (FVIII). In the past decades, structural studies using X-ray crystallography, cryo-electron microscopy (cryo-EM), nuclear magnetic resonance (NMR), and molecular modeling have revealed the architecture of nearly every domain. This review provides an examination of VWF's molecular architecture, the structural basis of its interactions, and the implications of structural insights for disease understanding and therapy.

Keywords

domain structure - VWF - von Willebrand disease

Publication History

Received: 02 November 2025

Accepted: 19 November 2025

Article published online:
17 February 2026

• References

• 1 Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395-424
• 2 Mansouri Taleghani M, von Krogh AS, Fujimura Y. et al. Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry. Hamostaseologie 2013; 33 (02) 138-143
• 3 Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997; 89 (09) 3097-3103
• 4 Gerritsen HE, Robles R, Lämmle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 2001; 98 (06) 1654-1661
• 5 Crawley JT, de Groot R, Xiang Y, Luken BM, Lane DA. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood 2011; 118 (12) 3212-3221
• 6 Zhou YF, Eng ET, Zhu J, Lu C, Walz T, Springer TA. Sequence and structure relationships within von Willebrand factor. Blood 2012; 120 (02) 449-458
• 7 Lippok S, Kolšek K, Löf A. et al. von Willebrand factor is dimerized by protein disulfide isomerase. Blood 2016; 127 (09) 1183-1191
• 8 Zhou YF, Springer TA. Highly reinforced structure of a C-terminal dimerization domain in von Willebrand factor. Blood 2014; 123 (12) 1785-1793
• 9 Stockschlaeder M, Schneppenheim R, Budde U. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis. Blood Coagul Fibrinolysis 2014; 25 (03) 206-216
• 10 Nightingale T, Cutler D. The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story. J Thromb Haemost 2013; 11 (Suppl. 01) 192-201
• 11 Giblin JP, Hewlett LJ, Hannah MJ. Basal secretion of von Willebrand factor from human endothelial cells. Blood 2008; 112 (04) 957-964
• 12 McKinnon TA, Goode EC, Birdsey GM. et al. Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factor. Blood 2010; 116 (04) 640-648
• 13 McGrath RT, van den Biggelaar M, Byrne B. et al. Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis. Blood 2013; 122 (25) 4107-4110
• 14 Nowak AA, Canis K, Riddell A, Laffan MA, McKinnon TA. O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions. Blood 2012; 120 (01) 214-222
• 15 Solecka BA, Weise C, Laffan MA, Kannicht C. Site-specific analysis of von Willebrand factor O-glycosylation. J Thromb Haemost 2016; 14 (04) 733-746
• 16 Wagner DD, Mayadas T, Marder VJ. Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor. J Cell Biol 1986; 102 (04) 1320-1324
• 17 Da Q, Nolasco J, Khatlani T, Maria F, Cruz MA, Vijayan KV. FAM20c-mediated serine 1613 phosphorylation in the A2 domain of von Willebrand factor regulates ADAMTS13 activity and thrombus formation. Blood 2015; 126 (23) 236-236
• 18 Shiltagh N, Kirkpatrick J, Cabrita LD. et al. Solution structure of the major factor VIII binding region on von Willebrand factor. Blood 2014; 123 (26) 4143-4151
• 19 Dong X, Leksa NC, Chhabra ES. et al. The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis. Blood 2019; 133 (14) 1523-1533
• 20 Jorieux S, Gaucher C, Goudemand J, Mazurier C. A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization. Blood 1998; 92 (12) 4663-4670
• 21 Colombatti A, Bonaldo P. The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Blood 1991; 77 (11) 2305-2315
• 22 Romijn RA, Bouma B, Wuyster W. et al. Identification of the collagen-binding site of the von Willebrand factor A3-domain. J Biol Chem 2001; 276 (13) 9985-9991
• 23 Emsley J, Cruz M, Handin R, Liddington R. Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib. J Biol Chem 1998; 273 (17) 10396-10401
• 24 Dumas JJ, Kumar R, McDonagh T. et al. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations. J Biol Chem 2004; 279 (22) 23327-23334
• 25 Zhang Q, Zhou YF, Zhang CZ, Zhang X, Lu C, Springer TA. Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor. Proc Natl Acad Sci U S A 2009; 106 (23) 9226-9231
• 26 Huizinga EG, Martijn van der Plas R, Kroon J, Sixma JJ, Gros P. Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding. Structure 1997; 5 (09) 1147-1156
• 27 Xu ER, von Bülow S, Chen PC. et al. Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor. Blood 2019; 133 (04) 366-376
• 28 Chen PC, Kutzki F, Mojzisch A. et al. Structure and dynamics of the von Willebrand Factor C6 domain. J Struct Biol 2022; 214 (04) 107923
• 29 Zeng J, Shu Z, Liang Q. et al. Structural basis of von Willebrand factor multimerization and tubular storage. Blood 2022; 139 (22) 3314-3324
• 30 Anderson JR, Li J, Springer TA, Brown A. Structures of VWF tubules before and after concatemerization reveal a mechanism of disulfide bond exchange. Blood 2022; 140 (12) 1419-1430
• 31 Celikel R, Varughese KI, Madhusudan, Yoshioka A, Ware J, Ruggeri ZM. Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab. Nat Struct Biol 1998; 5 (03) 189-194
• 32 Fukuda K, Doggett TA, Bankston LA, Cruz MA, Diacovo TG, Liddington RC. Structural basis of von Willebrand factor activation by the snake toxin botrocetin. Structure 2002; 10 (07) 943-950
• 33 Huang RH, Fremont DH, Diener JL, Schaub RG, Sadler JE. A structural explanation for the antithrombotic activity of ARC1172, a DNA aptamer that binds von Willebrand factor domain A1. Structure 2009; 17 (11) 1476-1484
• 34 Lee HT, Park UB, Jeong TJ. et al. High-resolution structure of the vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine for treating acquired TTP. Biochem Biophys Res Commun 2021; 567: 49-55
• 35 Diener JL, Daniel Lagassé HA, Duerschmied D. et al. Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779. J Thromb Haemost 2009; 7 (07) 1155-1162
• 36 Jilma-Stohlawetz P, Knöbl P, Gilbert JC, Jilma B. The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease. Thromb Haemost 2012; 108 (02) 284-290
• 37 Löf A, König G, Schneppenheim S. et al. Advancing multimer analysis of von Willebrand factor by single-molecule AFM imaging. PLoS One 2019; 14 (01) e0210963
• 38 Csányi MC, Salamon P, Feller T, Bozó T, Hársfalvi J, Kellermayer MSZ. Structural hierarchy of mechanical extensibility in human von Willebrand factor multimers. Protein Sci 2023; 32 (01) e4535
• 39 Löf A, Walker PU, Sedlak SM. et al. Multiplexed protein force spectroscopy reveals equilibrium protein folding dynamics and the low-force response of von Willebrand factor. Proc Natl Acad Sci U S A 2019; 116 (38) 18798-18807
• 40 Müller JP, Löf A, Mielke S. et al. pH-dependent interactions in dimers govern the mechanics and structure of von Willebrand factor. Biophys J 2016; 111 (02) 312-322
• 41 Arya M, Anvari B, Romo GM. et al. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood 2002; 99 (11) 3971-3977
• 42 Fu H, Jiang Y, Yang D, Scheiflinger F, Wong WP, Springer TA. Flow-induced elongation of von Willebrand factor precedes tension-dependent activation. Nat Commun 2017; 8 (01) 324
• 43 Schrödinger, LCC, The PyMOL Molecular Graphics System. Version 1.5.0.4. 2010